Donald Trump has proposed a 200 per cent tariff on Australian pharmaceuticals, an export worth over two billion Australian dollars.
These fresh tariffs are being seen as retaliation against the pharmaceutical benefit scheme, which US corporations see as a barrier to profits.
Producers: